
CBFB::MYH11 Inversion(16), Quantitative Detection and Minimal Disease Risk Monitoring, qRT-PCR, Varies
64
Overview
"CBFB::MYH11 Inversion(16), Quantitative Detection and Minimal Disease Risk Monitoring, qRT-PCR, Varies" refers to a molecular diagnostic approach aimed at detecting and quantifying a chromosomal inversion involving the CBFB and MYH11 genes in AML patients using qRT-PCR, with the purpose of assessing disease risk and monitoring minimal residual disease.
WHAT IS IT USED FOR?
Detecting the fusion of the CBFB and MYH11 genes in individuals newly diagnosed with acute myeloid leukemia (AML), and monitoring minimal residual disease throughout the clinical and therapeutic journey of AML patients.
METHOD NAME
Quantitative Real-Time Reverse Transcription Polymerase Chain Reaction (qRT-PCR)
AVAILABILITY
TBC
REPORTING NAME
Inv(16); CBFB-MYH11, Quant, V
OTHER NAMES
Inv(16)
T(16;16)
Inv(16)(p13.1q22)
T(16;16)(p13.1;q22)
CBFB-MYH11
AML M4 Eo